How ChatGPT and Gemini Describe CROs and CDMOs: A First Look
When a sponsor or biotech founder asks ChatGPT which CROs to shortlist, a handful of companies come back. Most commercial teams don't know if they're on that list, or what AI says about them when they are.
We asked ChatGPT, Gemini, Perplexity and Google's AI Overviews how they describe and compare 15 CROs and CDMOs. This is a first look at the findings.
You'll leave with
Who gets named, who gets missed, and where AI gets capabilities wrong
What drives visibility for therapeutic areas and modalities
Three checks your marketing and BD team can run this week
45 minutes: 20 min findings, 10 min drivers, 15 min Q&A.
For commercial, marketing and BD leaders at CROs, CDMOs, biotech, tools and life science service companies.
Can't attend live? Register and we'll send the recording.
Part of the Marketing Stack community, powered by FTA Global. Life sciences professionals only. No sales pitches.
